Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Martino R, Garcia-Cadenas I, Esquirol A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation. Bone Marrow Transplant 2021 Oct 28. pii: 10.1038/s41409-021-01507.
PMID: 34711914


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016